Navigation Links
A reductionist approach to HIV research
Date:11/30/2009

A major obstacle to HIV research is the virus's exquisite specialisation for its human host meaning that scientists' traditional tools, like the humble lab mouse, can deliver only limited information. Now, a team of researchers writing in BioMed Central's open access Journal of Biology have made an ingenious assault on this problem by creating a mouse that has key features of HIV infection without being infected with HIV.

George Kassiotis, from the Division of Immunoregulation at MRC National Institute for Medical Research, worked with a team of researchers to create mice whose CD4+ T cells, the cells eliminated by HIV infection, commit a kind of suicide upon activation. He said, "Although these mice do not fully reproduce every aspect of human HIV-associated immune dysfunction, they do approximate two key immune alterations - CD4+ T cell immune deficiency and generalized immune activation. Further definition of the precise balance between CD4+ T cell killing and immune activation and deficiency will be vital to our understanding of the pathogenesis of immune deficiency virus infection."

The CD4+ T cells in the researchers' mice were engineered to express a toxin, diphtheria toxin A fragment, upon activation. This genetic self-destruct system causes the death of the cell within 48 hours. The resultant loss of activated immune cells caused the mice to exhibit symptoms with some similarities to those of immunodeficiency virus infection. There are clear differences between the mouse and a human infected with HIV, however, such as the fact that the ongoing depletion of nearly all activated CD4+ T cells in the mice does not result in the progressive erosion of nave and memory CD4+ T cells seen during HIV infection. None-the-less, insights gained from this reductionist model can only help our understanding of human disease. In a commentary on the work in the same issue of Journal of Biology, experts on T cells and HIV at the US National Institutes of Health comment that the mouse will be as useful for its differences from human infection as it will for its similarities.


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-319-22165
BioMed Central
Source:Eurekalert

Related biology news :

1. ORNL, Los Alamos pioneer new approach to assist scientists, farmers
2. Kill the cancer, not the patient: New toxicity testing approach could make chemo drugs safer
3. UTs Valentin Dragoi gets $1.2 million grant for groundbreaking approach to brain research
4. Systems biology recommended as a clinical approach to cancer
5. New tracking approach will help protect polar bears
6. Manatees can probably hear which directions boats approach from
7. Equity concerns raised by congestion pricing can be addressed to make approach viable
8. Combined stem cell-gene therapy approach cures human genetic disease in vitro
9. Rapid approach to identify influenza A virus mutations and drug resistance developed
10. Novel vaccine approach offers hope in fight against HIV
11. Stowers researchers develop whole genome sequencing approach for mutation discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a leading ... the release of its patent-pending calibration device. With this ... perform calibrations, securely upload data logs and process repairs ... customer. "Fighting drunk driving through the application ... public at large, but also for the customer who ...
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CESĀ® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its ... the leading personal genetics company, recently released its latest children,s ... . The book focuses on the topics of inheritance and ... Science Standards (NGSS) taught in elementary school classrooms in the ... a series by illustrator Ariana Killoran , whose previous ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... Bioscience, Inc. (NASDAQ: ROKA ), a molecular diagnostics company ... pathogens today announced the appointment of Mary Duseau as ... Company,s President and CEO since 2009, who will assume the position ... effective today. In addition, Ms. Duseau will join the ... ...
(Date:1/17/2017)... 17, 2017   Pulmatrix, Inc . (NASDAQ: ... innovative inhaled therapies to address serious pulmonary diseases, today ... in the lungs of CF patients, PUR1900, has been ... the U.S. Food & Drug Administration. Under ... speed the development of novel drugs against important pathogens, ...
(Date:1/17/2017)... , Jan. 17, 2017 Research and ... "Molecular Diagnostics - Technologies, Markets and Companies" to ... ... has increased remarkably during the past few years. More than ... molecular diagnostics and 342 of these are profiled in the ...
(Date:1/17/2017)... 17, 2017  Northwell Health today announced a ... precision cancer research. As ... care provider, Northwell Health diagnoses and treats 19,000 ... a Germany -based oncology research ... they will greatly expand cancer biobanking activities within ...
Breaking Biology Technology: